RPS6KB1 and cancer: To determine the kinetics of p-S6K1 inhibition by Super-EBS, we tested various therapy-sensitive and therapy-resistant cancer cell lines (A549, PC-9-OR, LNCaP, M49F) for p-S6K1 expression in response to Super-EBS and EBS.